The discovery and initial optimisation of pyrrole-2-carboxamides as inhibitors of p38alpha MAP kinase.
Down, K., Bamborough, P., Alder, C., Campbell, A., Christopher, J.A., Gerelle, M., Ludbrook, S., Mallett, D., Mellor, G., Miller, D.D., Pearson, R., Ray, K., Solanke, Y., Somers, D.(2010) Bioorg Med Chem Lett 20: 3936-3940
- PubMed: 20570148 
- DOI: https://doi.org/10.1016/j.bmcl.2010.05.011
- Primary Citation of Related Structures:  
3MPT - PubMed Abstract: 
A novel pyrrole-2-carboxamide series of p38alpha inhibitors, discovered through the application of virtual screening, is presented. Following evaluation of activity, selectivity and developability properties of commercially available analogues, a synthesis program enabled rapid assessment of the series' suitability for further lead optimisation studies.
Organizational Affiliation: 
GlaxoSmithKline R&D, Medicines Research Centre, Stevenage, Hertfordshire, UK. kenneth.d.down@gsk.com